Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/35449
Title: | The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC | Authors: | Coats, AJS Anker, SD Baumbach, A Alfieri, O Von Bardeleben, RS Bauersachs, J Bax, JJ Boveda, S Celutkiene, J Cleland, JG Dagres, N Deneke, T Farmakis, D Filippatos, G Hausleiter, J Hindricks, G Jankowska, EA Lainscak, M Leclercq, C Lund, LH McDonagh, T Mehra, MR Metra, M Mewton, N Mueller, C MULLENS, Wilfried Muneretto, C Obadia, JF Ponikowski, P Praz, F Rudolph, V Ruschitzka, F Vahanian, A Windecker, S Zamorano, JL Edvardsen, T HEIDBUCHEL, Hein Seferovic, PM Prendergast, B |
Issue Date: | 2021 | Publisher: | OXFORD UNIV PRESS | Source: | European heart journal, 42 (13) , p. 1254 -1269 | Abstract: | Secondary (or functional) mitral regurgitation (SMR) occurs frequently in chronic heart failure (HF) with reduced left ventricular (LV) ejection fraction, resulting from LV remodelling that prevents coaptation of the valve leaflets. Secondary mitral regurgitation contributes to progression of the symptoms and signs of HF and confers worse prognosis. The management of HF patients with SMR is complex and requires timely referral to a multidisciplinary Heart Team. Optimization of pharmacological and device therapy according to guideline recommendations is crucial. Further management requires careful clinical and imaging assessment, addressing the anatomical and functional features of the mitral valve and left ventricle, overall HF status, and relevant comorbidities. Evidence concerning surgical correction of SMR is sparse and it is doubtful whether this approach improves prognosis. Transcatheter repair has emerged as a promising alternative, but the conflicting results of current randomized trials require careful interpretation. This collaborative position statement, developed by four key associations of the European Society of Cardiology-the Heart Failure Association (HFA), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association of Cardiovascular Imaging (EACVI), and European Heart Rhythm Association (EHRA)-presents an updated practical approach to the evaluation and management of patients with HF and SMR based upon a Heart Team approach. | Keywords: | Heart failure;Secondary mitral regurgitation;Functional mitral regurgitation;Transcatheter mitral valve repair | Document URI: | http://hdl.handle.net/1942/35449 | ISSN: | 0195-668X | e-ISSN: | 1522-9645 | DOI: | 10.1093/eurheartj/ehab086 | ISI #: | 000646252800013 | Rights: | VC The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2022 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ehab086.pdf | Published version | 6.38 MB | Adobe PDF | View/Open |
WEB OF SCIENCETM
Citations
74
checked on Apr 22, 2024
Page view(s)
22
checked on Jul 22, 2022
Download(s)
10
checked on Jul 22, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.